Photo test in kansas

They companies “top-line results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a 30-µg booster dose of the Pfizer-BioNTech Covid-19 vaccine in more than 10,000 individuals 16 years of age and older.”

The companies plan to give the data to the FDA, the European Medicines Agency and other regulators worldwide.

At last check shares of Pfizer, the New York health-care group, were little changed at $42.83 while BioNTech shares dropped 4.3% to $274.13


This story was originally published October 22, 2021 10:06 AM.

This text must be displayed instead the one on the feature file

testing that in CTA section param info supersedes the configuration in the feature file

subscribe test!


Testing Kansas

Updated May 02, 2022 4:16 PM


vrvee rgbngyn

Updated March 09, 2022 4:31 PM


Testing :P 2

Updated February 18, 2022 10:52 AM
Copyright Commenting Policy Privacy Policy Terms of Service